ZURA
Zura Bio Ltd
-0.01 (-0.22%)4.60USD840K成交股數441M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 20.7M | 14.7M | 11.9M | 8.7M | 10.5M | 9.2M | 6.0M | 5.5M | 3.6M | 4.0M | 28.2M | 4.9M |
| 銷售管理費用 | 8.6M | 10.8M | 7.6M | 9.4M | 8.8M | 6.5M | 13.3M | 6.2M | 4.8M | 6.2M | 5.7M | 2.8M |
| 營業利益 | −29.3M+52% | −25.5M+62% | −19.5M+1% | −18.1M+54% | −19.3M+130% | −15.7M+54% | −19.3M-43% | −11.8M+52% | −8.4M | −10.2M | −33.9M | −7.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −26.3M+51% | −24.2M+78% | −18.0M-13% | −16.0M+55% | −17.4M+125% | −13.6M+65% | −20.7M-39% | −10.3M+8% | −7.7M | −8.3M | −34.0M | −9.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.21+11% | -0.22+47% | -0.21-19% | -0.170% | -0.19+850% | -0.15-17% | -0.26-80% | -0.17-94% | -0.02 | -0.18 | -1.31 | -2.76 |
| 稀釋股數 | 127M | 112M | 94.6M | 94.3M | 93.0M | 75.1M | 87.3M | 74.9M | 46.9M | 46.9M | 34.3M | 3.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 205M | 226M | 139M | 154M | 171M | 176M | 188M | 188M | 89.8M | 104M | 113M | 44.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 213M | 229M | 144M | 158M | 172M | 180M | 189M | 190M | 90.5M | 105M | 113M | 44.4M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 16.3M | 11.7M | 25.5M | 18.7M | 21.1M | 19.5M | 18.2M | 17.4M | 16.3M | 19.0M | 22.0M | 6.5M |
| 股東權益 | 197M | 217M | 108M | 126M | 138M | 147M | 153M | 157M | 61.0M | 63.2M | 68.9M | 27.9M |
| 負債比 | 7.6% | 5.1% | 17.7% | 11.8% | 12.2% | 10.9% | 9.6% | 9.2% | 18.0% | 18.1% | 19.4% | 14.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −18.9M | – | – | −11.1M+122% | – | – | – | −5.0M | – | – | −3.3M |
| 資本支出 | – | 13K | – | – | 49K | – | – | – | 7K | – | – | – |
| 自由現金流 | – | −18.9M | – | – | −11.1M+123% | – | – | – | −5.0M | – | – | – |
| 折舊攤銷 | – | 16K | – | – | 9K | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −68.7M | –% | -1.06 | −64.9M |
| FY2024 | – | – | −52.4M | –% | -0.60 | −28.2M |
| FY2023 | – | – | −60.4M | –% | -2.09 | – |
| FY2022 | – | – | −25.7M | –% | -141.97 | – |